Pulmonary Vascular Complications of Chronic Liver Disease
Author Information
Author(s): Khan Ali Nawaz Al-Jahdali, Abdullah Khalid, Irion Klaus L., Sabih Quratulain, Gouda Alaa
Primary Institution: North Manchester General Hospital, Manchester, Pennine Acute Hospitals NHS Trust, UK
Hypothesis
To review current knowledge and advances made in understanding pulmonary vascular complications of liver disease between 2000 and 2010.
Conclusion
The study emphasizes the importance of understanding the pathogenesis of pulmonary vascular complications and their implications for treatment and prognosis.
Supporting Evidence
- Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPH) are significant complications of chronic liver disease.
- HPS can lead to hypoxemia and worsens the prognosis of cirrhotic patients.
- Liver transplantation is the only definitive treatment for HPS, with a high rate of reversal post-surgery.
Takeaway
This study looks at how liver disease can cause problems in the lungs and what doctors can do to help patients with these issues.
Methodology
The MEDLINE database was explored through PubMed, and bibliographies of 229 papers were reviewed, including case studies and series reporting results from patients with vascular complications of chronic liver disease.
Limitations
The review is based on existing literature and may not include the most recent studies or findings beyond 2010.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website